The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
Thyroid cancer is uncommon and exhibits relatively low mortality rates. However, a subset of patients experience inexorable growth, metastatic spread, and mortality. Unfortunately, for these patients, there have been few significant advances in treatment during the last 50 years. While substantial a...
Saved in:
Main Authors: | Kimberly A. Placzkowski, Honey V. Reddi, Stefan K. G. Grebe, Norman L. Eberhardt, Bryan McIver |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/672829 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Undifferentiated Malignant Neoplasm Involving Parotid and Thyroid: Sampling and PAX8 Cross-Reactivity Can Obscure the Diagnosis of Lymphoma
by: Elizabeth W. Hubbard, et al.
Published: (2016-01-01) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01) -
PAX8 Distinguishes Diffuse Large B-Cell Lymphoma Mimicking Sarcoma
by: Michelle S. Hirsch, et al.
Published: (2017-01-01) -
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01) -
Overexpression of PAX8-AS1 Inhibits Malignant Phenotypes of Papillary Thyroid Carcinoma Cells via miR-96-5p/PKN2 Axis
by: Ping Zhou, et al.
Published: (2021-01-01)